§ PHARMACEUTICALS
USD · Pharmaceuticals

SNDL

SNDL INC
USDSector · Pharmaceuticals
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
Morgan Stanley IM11.4M0.0%−54%
CANNELL CAPITAL LLC8.8M7.1%±0%
Tidal Investments LLC5.5M0.0%+7%
AdvisorShares Investments LLC3.5M0.8%−4%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP3.0M0.0%−27%
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.2.2M0.0%+17%
AC INTELLIGENCE

Top institutional owners for SNDL as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER76.7% · 1 holder
OTHER12.8% · 85 holders
DEALER / BANK6.0% · 12 holders
SYSTEMATIC / QUANT2.2% · 4 holders
TACTICAL / MACRO1.2% · 2 holders
PASSIVE / INDEX1.1% · 3 holders
QUALITY / COMPOUNDER0.1% · 1 holder
AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
AC INTELLIGENCE

No Form 4 filings on record for SNDL in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention SNDL yet.